Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castrate Resistant Prostate Cancer (mCRPC) 2Severe Acute Respiratory Syndrome 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Neoadjuvant Therapy \High Risk Prostate Cancer 1COVID-19 1Breast Neoplasms 1Alopecia 1

Interventions

Dutasteride 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Transurethral Resection of Prostate 2Therapeutics 2Radiotherapy 2Prostatectomy 2Blood Specimen Collection 2proxalutamide 1polyphenon E 1mirabegron 1Urination 1TroVax 1Transurethral Resection of Bladder 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Psychiatric Rehabilitation 1Prostate-Specific Antigen 1Papaverine 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Magnetic Resonance Spectroscopy 1Lycopene 1Levofloxacin 1Finasteride 1Electroacupuncture 1Doxazosin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Hyperplasia × proxalutamide × Clear all
NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Applied Biology, Inc.

Phase NA Completed
268 enrolled 8 charts
Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡